Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793435What this trial is testingA Phase 1/2 Trial of ADI-212 in mCRPCWho this might be right forProstate Cancer Metastatic Adicet Therapeutics 12
Early research (Phase 1)Study completedNCT06377683What this trial is testingClinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer, mCRPC The First Affiliated Hospital of Xiamen University 8
Large-scale testing (Phase 3)Looking for participantsNCT06629779What this trial is testingLearn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Who this might be right forMetastatic Castration-Resistant Prostate Cancer Pfizer 900
Testing effectiveness (Phase 2)Ended earlyNCT04458311What this trial is testingAbiraterone Acetate in Combination With TildrakizumabWho this might be right forMetastatic Castration Resistant Prostate Cancer Institute of Cancer Research, United Kingdom 13
Large-scale testing (Phase 3)Active Not RecruitingNCT03574571What this trial is testingTest Radium-223 With Docetaxel in Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 732
Testing effectiveness (Phase 2)Study completedNCT02928432What this trial is testingSWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With AbirateroneWho this might be right forProstate Cancer Centro Nacional de Investigaciones Oncologicas CARLOS III 26
Not applicableLooking for participantsNCT07302763What this trial is testingFour-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer HeterogeneityWho this might be right formCRPC (Metastatic Castration-resistant Prostate Cancer) Frederic Pouliot 45
Early research (Phase 1)UnknownNCT06344715What this trial is testingPhase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.Who this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC) SL VAXiGEN 78
Early research (Phase 1)Active Not RecruitingNCT06046040What this trial is testingTmPSMA-02 in mCRPCWho this might be right forMetastatic Castrate-Resistant Prostate Cancer (mCRPC) University of Pennsylvania 30
Large-scale testing (Phase 3)Looking for participantsNCT03903835What this trial is testingProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Karolinska Institutet 750
Not applicableStudy completedNCT03223597What this trial is testingRegistry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223Who this might be right forProstate Cancer MetastaticBone Metastases The Netherlands Cancer Institute 300
Testing effectiveness (Phase 2)Looking for participantsNCT05413850What this trial is testingAnti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionWho this might be right forProstate CancerMetastatic Castration-resistant Prostate CancermCRPC+3 more Blue Earth Therapeutics Ltd 82
Large-scale testing (Phase 3)Study completedNCT03295565What this trial is testingOptimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelWho this might be right forProstate Cancer MetastaticMetastasis The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT07181161What this trial is testingStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer AstraZeneca 283
Testing effectiveness (Phase 2)UnknownNCT06001255What this trial is testingARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid TumorsWho this might be right forMetastasis Castration Resistant Prostate Cancer(mCRPC) Hansoh BioMedical R&D Company 120
Large-scale testing (Phase 3)Looking for participantsNCT03851640What this trial is testingA Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).Who this might be right forMCRPC Hinova Pharmaceuticals Inc. 417
Testing effectiveness (Phase 2)Looking for participantsNCT05168618What this trial is testingCabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more University of Utah 33
Large-scale testing (Phase 3)Not Yet RecruitingNCT07632690What this trial is testingQLC5508 in Participants With Metastatic Prostate CancerWho this might be right forProstate Cancer Qilu Pharmaceutical Co., Ltd. 700
Testing effectiveness (Phase 2)Study completedNCT03434158What this trial is testingOlaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)Who this might be right forProstate Cancer Metastatic Spanish Oncology Genito-Urinary Group 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07608718What this trial is testingPhase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Pedro Barata, MD, MSc 19